Quick Takeaways
- BDSX - BIODESIX INC has 15 insiders with reported activity on this page.
- Net insider value flow over the last year: +$4,777,968.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 15 Insiders of BIODESIX INC
- Symbol
- BDSX on Nasdaq
- Location
- Louisville, CO
What Changed
- Buy value: $4,900,921; sell value: $122,953.
- Net share flow: +8,370,958.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$4,777,968.
Buys
$4,900,921
Shares: 8,394,076
Insiders: 1
Sells
$122,953
Shares: 23,118
Insiders: 5
Net
+$4,777,968
Shares: +8,370,958
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 20,000 | 9,052 | $236,064 | $100,236 | +$135,828 |
| 3-6 | 162,465 | 2,247 | $1,848,233 | $18,153 | +$1,830,080 |
| 6-9 | 3,488,372 | 5,906 | $1,500,000 | $2,459 | +$1,497,541 |
| 9-12 | 4,723,239 | 5,913 | $1,316,624 | $2,106 | +$1,314,519 |
BIODESIX INC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jack W. Schuler | Emeritus Director, 10%+ Owner | $23,551,330 | +$4,900,921 | +26% | Mixed | 23 Jan 2026 |
| John Patience | Director, Chairman | $2,555,541 | Mixed | 31 Mar 2026 | ||
| Scott Hutton | President & CEO, Director | $981,155 | -$67,185 | -6.4% | Mixed | 20 Feb 2026 |
| Charles M. Watts | Director | $389,740 | Mixed | 31 Mar 2025 | ||
| Robin Harper Cowie | CFO, Sec'y & Treasurer | $315,954 | -$19,898 | -5.9% | Mixed | 20 Feb 2026 |
| Gary Anthony Pestano | Chief Development Officer | $245,279 | -$15,495 | -5.9% | Mixed | 20 Feb 2026 |
| Kieran O'Kane | Chief Commercial Officer | $234,037 | -$15,711 | -6.3% | Mixed | 20 Feb 2026 |
| Hany Massarany | Director | $133,092 | Mixed | 02 Jan 2026 | ||
| Jean M. Franchi | Director | $99,943 | Mixed | 02 Jan 2026 | ||
| Chris Vazquez | Chief Accounting Officer | $61,897 | -$4,664 | -7% | Mixed | 20 Feb 2026 |
| Ryan H. Siurek | Chief Accounting Officer | $53,711 | Mixed | 08 May 2023 | ||
| Robert William Georgantas III | Chief Scientific Officer | $46,836 | Mixed | 21 Nov 2022 | ||
| Matthew W. Strobeck | Director | $22,565 | Mixed | 02 Jan 2026 | ||
| Lawrence T. Kennedy Jr. | Director, 10%+ Owner | $19,608 | Mixed | 02 Jan 2026 | ||
| Jon Faiz Kayyem | Director | $19,608 | Mixed | 02 Jan 2026 |
Top shareholders of BIODESIX INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jack W. Schuler |
3/4/5
13D/G
|
Emeritus Director, 10%+ Owner · SCHULER JACK W |
24%
from 13D/G
|
2,313,210
|
$23,551,330 | +$4,900,921 | 23 Jan 2026 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
5.1%
|
7,673,880
|
$4,374,112 | +$570,000 | 12 May 2025 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
6.3%
|
500,000
|
$4,000,000 | $0 | 12 Jan 2026 | |
| Telemark Asset Management, LLC |
13D/G
13F
|
Company |
5.4%
|
427,824
|
$2,909,460 | +$680,060 | 22 Jan 2026 | |
| John Patience |
3/4/5
|
Director, Chairman |
—
mixed-class rows
|
386,251
mixed-class rows
|
$2,555,541 | — | 31 Mar 2026 | |
| Birchview Capital, LP |
13F
|
Company |
0.19%
|
286,804
|
$1,950,267 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
2.7%
|
262,425
|
$1,784,490 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
192,138
|
$1,306,538 | — | 31 Dec 2025 | |
| Scott Hutton |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
160,298
mixed-class rows
|
$981,155 | -$67,185 | 20 Feb 2026 | |
| Monashee Investment Management LLC |
13F
|
Company |
1.2%
|
112,344
|
$763,939 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.66%
|
64,483
|
$438,000 | — | 31 Dec 2025 | |
| Charles M. Watts |
3/4/5
|
Director |
—
mixed-class rows
|
458,755
mixed-class rows
|
$389,740 | — | 31 Mar 2025 | |
| Robin Harper Cowie |
3/4/5
|
CFO, Sec'y & Treasurer |
—
mixed-class rows
|
49,637
mixed-class rows
|
$315,954 | -$19,898 | 20 Feb 2026 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.46%
|
44,783
|
$304,524 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
42,453
|
$288,753 | — | 31 Dec 2025 | |
| Gary Anthony Pestano |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
40,941
mixed-class rows
|
$245,279 | -$15,495 | 20 Feb 2026 | |
| Kieran O'Kane |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
41,225
mixed-class rows
|
$234,037 | -$15,711 | 20 Feb 2026 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.34%
|
33,017
|
$224,516 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.28%
|
27,542
|
$187,286 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
25,985
|
$176,698 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
24,466
|
$166,369 | — | 31 Dec 2025 | |
| Hany Massarany |
3/4/5
|
Director |
—
mixed-class rows
|
377,337
mixed-class rows
|
$133,092 | — | 02 Jan 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
17,802
|
$121,054 | — | 31 Dec 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.17%
|
16,145
|
$109,786 | — | 31 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.16%
|
15,372
|
$104,529 | — | 31 Dec 2025 | |
| Jean M. Franchi |
3/4/5
|
Director |
—
mixed-class rows
|
122,658
mixed-class rows
|
$99,943 | — | 02 Jan 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
11,134
|
$75,711 | — | 31 Dec 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.1%
|
10,000
|
$68,000 | — | 31 Dec 2025 | |
| Chris Vazquez |
3/4/5
|
Chief Accounting Officer |
—
mixed-class rows
|
15,275
mixed-class rows
|
$61,897 | -$4,664 | 20 Feb 2026 | |
| Ryan H. Siurek |
3/4/5
|
Chief Accounting Officer |
—
mixed-class rows
|
43,825
mixed-class rows
|
$53,711 | — | 08 May 2023 | |
| Robert William Georgantas III |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
38,214
|
$46,836 | — | 21 Nov 2022 | |
| Allworth Financial LP |
13F
|
Company |
0.05%
|
4,965
|
$33,762 | — | 31 Dec 2025 | |
| Matthew W. Strobeck |
3/4/5
|
Director |
—
mixed-class rows
|
13,158
mixed-class rows
|
$22,565 | — | 02 Jan 2026 | |
| Jon Faiz Kayyem |
3/4/5
|
Director |
—
mixed-class rows
|
11,797
mixed-class rows
|
$19,608 | — | 02 Jan 2026 | |
| Lawrence T. Kennedy Jr. |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
11,797
mixed-class rows
|
$19,608 | — | 02 Jan 2026 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
193
|
$1,312 | — | 31 Dec 2025 | |
| Quattro Advisors LLC |
13F
|
Company |
0%
|
187
|
$1,272 | — | 31 Dec 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
0%
|
171
|
$1,163 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
143
|
$972 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
100
|
$680 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
61
|
$415 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
1
|
$7 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for BIODESIX INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John Patience | BDSX | Common Stock | Options Exercise | 6.01% | 1,361 | 24,022 | 31 Mar 2026 | Direct | ||
| John Patience | BDSX | Restricted Stock Units | Options Exercise | -25% | -1,361 | 4,082 | 31 Mar 2026 | Direct | ||
| Gary Anthony Pestano | BDSX | Common Stock | Sale | -5.09% | $7,103 | $12.78 | -556 | 10,359 | 23 Feb 2026 | Direct |
| Kieran O'Kane | BDSX | Common Stock | Sale | -5.17% | $6,835 | $12.78 | -535 | 9,819 | 23 Feb 2026 | Direct |
| Robin Harper Cowie | BDSX | Common Stock | Sale | -3.19% | $6,835 | $12.78 | -535 | 16,231 | 23 Feb 2026 | Direct |
| Chris Vazquez | BDSX | Common Stock | Sale | -11.7% | $2,696 | $12.78 | -211 | 1,586 | 23 Feb 2026 | Direct |
| Scott Hutton | BDSX | Common Stock | Sale | -2.96% | $19,036 | $12.78 | -1,490 | 48,767 | 23 Feb 2026 | Direct |
| Gary Anthony Pestano | BDSX | Common Stock | Options Exercise | 16.3% | 1,528 | 10,915 | 20 Feb 2026 | Direct | ||
| Gary Anthony Pestano | BDSX | Restricted Stock Units | Options Exercise | -25% | -1,528 | 4,582 | 20 Feb 2026 | Direct | ||
| Kieran O'Kane | BDSX | Common Stock | Options Exercise | 16.5% | 1,469 | 10,354 | 20 Feb 2026 | Direct | ||
| Kieran O'Kane | BDSX | Restricted Stock Units | Options Exercise | -25% | -1,469 | 4,406 | 20 Feb 2026 | Direct | ||
| Robin Harper Cowie | BDSX | Common Stock | Options Exercise | 9.6% | 1,469 | 16,766 | 20 Feb 2026 | Direct | ||
| Robin Harper Cowie | BDSX | Restricted Stock Units | Options Exercise | -25% | -1,469 | 4,406 | 20 Feb 2026 | Direct | ||
| Chris Vazquez | BDSX | Common Stock | Options Exercise | 45.6% | 563 | 1,797 | 20 Feb 2026 | Direct | ||
| Chris Vazquez | BDSX | Restricted Stock Units | Options Exercise | -25% | -563 | 1,689 | 20 Feb 2026 | Direct | ||
| Scott Hutton | BDSX | Common Stock | Options Exercise | 10.7% | 4,844 | 50,257 | 20 Feb 2026 | Direct | ||
| Scott Hutton | BDSX | Restricted Stock Units | Options Exercise | -25% | -4,844 | 14,531 | 20 Feb 2026 | Direct | ||
| Kieran O'Kane | BDSX | Common Stock | Sale | -6.17% | $5,889 | $10.08 | -584 | 8,885 | 10 Feb 2026 | Direct |
| Chris Vazquez | BDSX | Common Stock | Sale | -7.57% | $1,018 | $10.08 | -101 | 1,234 | 10 Feb 2026 | Direct |
| Scott Hutton | BDSX | Common Stock | Sale | -7.27% | $35,889 | $10.08 | -3,559 | 45,413 | 10 Feb 2026 | Direct |
| Robin Harper Cowie | BDSX | Common Stock | Sale | -5.8% | $9,489 | $10.08 | -941 | 15,297 | 10 Feb 2026 | Direct |
| Gary Anthony Pestano | BDSX | Common Stock | Sale | -5.44% | $5,445 | $10.08 | -540 | 9,387 | 10 Feb 2026 | Direct |
| Kieran O'Kane | BDSX | Common Stock | Options Exercise | 20.3% | 1,600 | 9,469 | 09 Feb 2026 | Direct | ||
| Kieran O'Kane | BDSX | Restricted Stock Units | Options Exercise | -100% | -1,600 | 0 | 09 Feb 2026 | Direct | ||
| Chris Vazquez | BDSX | Common Stock | Options Exercise | 24.5% | 263 | 1,335 | 09 Feb 2026 | Direct | ||
| Chris Vazquez | BDSX | Restricted Stock Units | Options Exercise | -100% | -263 | 0 | 09 Feb 2026 | Direct | ||
| Scott Hutton | BDSX | Common Stock | Options Exercise | 25.6% | 9,998 | 48,972 | 09 Feb 2026 | Direct | ||
| Scott Hutton | BDSX | Restricted Stock Units | Options Exercise | -100% | -9,998 | 0 | 09 Feb 2026 | Direct | ||
| Robin Harper Cowie | BDSX | Common Stock | Options Exercise | 18.9% | 2,584 | 16,238 | 09 Feb 2026 | Direct | ||
| Robin Harper Cowie | BDSX | Restricted Stock Units | Options Exercise | -100% | -2,584 | 0 | 09 Feb 2026 | Direct | ||
| Gary Anthony Pestano | BDSX | Common Stock | Options Exercise | 17.5% | 1,481 | 9,927 | 09 Feb 2026 | Direct | ||
| Gary Anthony Pestano | BDSX | Restricted Stock Units | Options Exercise | -100% | -1,481 | 0 | 09 Feb 2026 | Direct | ||
| Jack W. Schuler | BDSX | Common Stock | Purchase | 1.3% | $236,064 | $11.80 | 20,000 | 1,563,210 | 26 Jan 2026 | By Jack W. Schuler Living Trust |
| Jack W. Schuler | BDSX | Common Stock | Purchase | 5.47% | $944,672 | $11.81 | 80,000 | 1,543,210 | 23 Jan 2026 | By Jack W. Schuler Living Trust |
| Jack W. Schuler | BDSX | Common Stock | Purchase | 5.97% | $903,561 | $10.96 | 82,465 | 1,463,210 | 22 Jan 2026 | By Jack W. Schuler Living Trust |
| Chris Vazquez | BDSX | Common Stock | Sale | -7.19% | $676 | $8.15 | -83 | 1,072 | 16 Jan 2026 | Direct |
| Gary Anthony Pestano | BDSX | Common Stock | Sale | -3.41% | $2,428 | $8.15 | -298 | 8,446 | 16 Jan 2026 | Direct |
| Kieran O'Kane | BDSX | Common Stock | Sale | -3.65% | $2,428 | $8.15 | -298 | 7,869 | 16 Jan 2026 | Direct |
| Scott Hutton | BDSX | Common Stock | Sale | -2.43% | $7,905 | $8.15 | -970 | 38,974 | 16 Jan 2026 | Direct |
| Robin Harper Cowie | BDSX | Common Stock | Sale | -2.14% | $2,428 | $8.15 | -298 | 13,654 | 16 Jan 2026 | Direct |
| Chris Vazquez | BDSX | Common Stock | Options Exercise | 23.4% | 219 | 1,155 | 15 Jan 2026 | Direct | ||
| Chris Vazquez | BDSX | Restricted Stock Units | Options Exercise | -33.4% | -219 | 436 | 15 Jan 2026 | Direct | ||
| Gary Anthony Pestano | BDSX | Common Stock | Options Exercise | 10.1% | 805 | 8,744 | 15 Jan 2026 | Direct | ||
| Gary Anthony Pestano | BDSX | Restricted Stock Units | Options Exercise | -33.4% | -805 | 1,609 | 15 Jan 2026 | Direct | ||
| Kieran O'Kane | BDSX | Common Stock | Options Exercise | 10.9% | 805 | 8,167 | 15 Jan 2026 | Direct | ||
| Kieran O'Kane | BDSX | Restricted Stock Units | Options Exercise | -33.4% | -805 | 1,609 | 15 Jan 2026 | Direct | ||
| Scott Hutton | BDSX | Common Stock | Options Exercise | 7.06% | 2,633 | 39,944 | 15 Jan 2026 | Direct | ||
| Scott Hutton | BDSX | Restricted Stock Units | Options Exercise | -33.3% | -2,633 | 5,265 | 15 Jan 2026 | Direct | ||
| Robin Harper Cowie | BDSX | Common Stock | Options Exercise | 6.12% | 805 | 13,952 | 15 Jan 2026 | Direct | ||
| Robin Harper Cowie | BDSX | Restricted Stock Units | Options Exercise | -33.4% | -805 | 1,609 | 15 Jan 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.